Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Inventory Average (2016 - 2025)

Corcept Therapeutics' Inventory Average history spans 9 years, with the latest figure at $13.3 million for Q2 2025.

  • For Q2 2025, Inventory Average rose 71.45% year-over-year to $13.3 million; the TTM value through Jun 2025 reached $13.3 million, up 71.45%, while the annual FY2024 figure was $10.1 million, 45.64% up from the prior year.
  • Inventory Average for Q2 2025 was $13.3 million at Corcept Therapeutics, down from $13.4 million in the prior quarter.
  • Across five years, Inventory Average topped out at $13.4 million in Q1 2025 and bottomed at $4.9 million in Q1 2021.
  • The 5-year median for Inventory Average is $7.5 million (2024), against an average of $8.0 million.
  • The largest annual shift saw Inventory Average grew 2.12% in 2022 before it skyrocketed 79.49% in 2025.
  • A 5-year view of Inventory Average shows it stood at $4.9 million in 2021, then rose by 6.67% to $5.3 million in 2022, then grew by 26.7% to $6.7 million in 2023, then soared by 53.57% to $10.2 million in 2024, then surged by 30.21% to $13.3 million in 2025.
  • Per Business Quant, the three most recent readings for CORT's Inventory Average are $13.3 million (Q2 2025), $13.4 million (Q1 2025), and $10.2 million (Q4 2024).